RFCL acquires Bremer Pharma
RFCL, an ICICI Venture company, has made first its global acquisition in the space of veterinary healthcare through a share purchase agreement with Marsing & Co A/S for its Germany-based subsidiary Bremer Pharma GmbH.
The company did not disclose the financial details of the agreement. The agreement is for transfer of all key people, assets, brands and the name ���Bremer Pharma��� and all contracts including exports.
RFCL will gain a marketing foothold and a manufacturing base in the country. The facility has a processing capacity of nearly 6.6 lakh litres of liquids per annum per shift, nearly 1,032 tonnes of solids per annum per shift and 15 lakh vials of sterile solutions per annum per shift.
Bremer Pharma is into research, manufacturing and supply of veterinary medical through a network across Europe, Middle East, Asia and Africa.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.